drugset / Trial / NCT04253704

Effects of 2% IDL Lotion on Skin Hydration and Transepidermal Water Loss in Females With Dry Skin

NCT04253704 ↗

Phase 1/2 Completed 16 enrolled Shyla Cantor Sytheon Ltd. · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

This was a placebo-controlled double-blinded trial to compare effects of 2% IDL lotion to placebo in female subjects with dry skin. Primary endpoints were skin hydration (NovaMeter) and transepidermal water loss (VapoMeter).

Timeline

Start
2017-02-13
Primary completion
2017-03-03
Completion
2017-03-03

Drugs

EvaluationDrugModalityDoseRoute
Subject isosorbide di-(linoleate/oleate) Unknown 2 % Topical

Indications

No indication recorded.